Friday, July 31, 2026

North Korea Appears to Be Scaling Up Solid-Fuel Missile Production at Ryongseong Machine Complex

Large-scale renovations are underway at Ryongsong Machine Complex, emphasized by Kim Jong-un during his visit in January.

South Korea Hits 15 North Korean IT Workers and Institution with Sanctions Over Cyber Thefts

South Korea imposed sanctions on 15 North Korean IT operatives for their role in funding nuclear programs through cyber activities.

Revolutionizing Work: How HSAD’s Deep Agent Builder Empowers AI-Driven Marketing in 2026

HSAD's Agent Builder Day showcased AI agent creation, enhancing workflows and marketing capabilities through user-friendly natural language inputs.

Tag: FDA approval

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

GC Biopharma Targets Full Utilization of Plasma Centers with FDA Approval of ABO Plasma

GC Biopharma's ABO Plasma gains FDA approval for its Laredo center, enhancing plasma sourcing and operational efficiency ahead of schedule.

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

J&J Aims to Treat Cancer Before It Starts Showing Symptoms

Johnson & Johnson leads in multiple myeloma treatment, pioneering early intervention for high-risk patients with a new subcutaneous formulation.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

FDA Greenlights CMG’s Film-Based Schizophrenia Medication ‘Mezofy’

CMG Pharmaceutical gains FDA approval for Mezofy, a unique oral film for schizophrenia, marking a milestone for South Korean pharma.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.